The European Medicines Agency (EMA) plans to release a reflection paper regarding when external controls can be used to generate evidence to support regulatory decisions on drug approvals. @The agency ...
As neurological conditions expose the limits of traditional clinical endpoints, Europe’s regulators are being pushed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback